Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.35 Analyst target: $13.83 Upside: 312.84%
Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. The company is headquartered in West Chester, Pennsylvania.
See the full interactive analysis & chart →Informational only — not investment advice.